Volume: 6 Issue: 2
Year: 2018, Page: 12-15,
Introduction: Clinical assessment of kidney function is part of routine medical care for adults. More than 80% of clinical laboratories now report an estimated glomerular filtration rate (GFR) when serum creatinine is measured. Variations in Non-GFR biochemical parameters like creatine can affect the differential diagnosis of renal disorders leading to unnecessary diagnostic interventions. In recent studiesof prognosis, Cystatin C is considered to be a potential alternative marker to serum creatinine for estimating GFR.cystatin C testing has been greatly improved by the release of a certified reference material for calibrating laboratory assays and by the development of new, less expensive methods for automated analyzers.
Aims and Objectives: To evaluate the role of serum Cystatin-C and serum creatinine for measuring eGFR using CKD-EPI equation in chronic kidney disease patients.
Materials and Methods :In this study comprising of two comparative groups consisting of 30 study participants each were enrolled in the study. Group-I includes30 normal healthy subjects, Group-II includes 30Chronic kidney disease patients. A random venous blood sample of 5ml was collected from each participant in a plain vaccutainer. Creatinine, Cystatin-C were estimated by using Erba & Accurex kits on XL-640 clinical chemistry analyzer.eGFR was calculated using CKD-EPI equation.
Results :The results of two groups are expressed as Mean±SD. The values of cystatin-C and serum creatinine were significantly increased in Chronic kidney disease (group-II) when compared with group-I (controls).
Statistical Analysis :The data was analyzed by calculating Mean±SD (123.7±36.28),(26.03±12.73), (104.90±29.17),(28.34±22.65) respectively for every parameter and ‘p’ value (0.0001) was calculated by applying student ‘t’ test using graph pad calculator. Correlation studies were done using Karl Pearson’s test. Statistical significance was considered at ‘p’-value0.0001 .
Conclusion : The present study suggests that eGFRcalculated using CKD-EPI equation using cystatin-C alone and combination of creatinine and cystatin-c can be used as an indicator for early prognosis of chronic kidney disease .
Keywords: Cystatin-C, Creatinine, Chronic kidney disease,eGFR
1. World Health OrganizationBurden of disease project (2004). http://www3.who.int/whosis/ menu.cfm?path=evidence,burden&language=english
2. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. ClinChimActa 2003;338:87–90.
3. Grubb A, Löfberg H. Human ?-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. ProcNatlAcadSci USA 1982;79:3024-7.
4. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004;41:467-50.
5. Tanaka A, Suemaru K, Araki H. A new approach for evaluating renal function and its practical application. J Pharmacol Sci 2007;105:1–5.
6. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD, 3rd, Zhang YL, Greene T, Levey AS. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008;51:395–406.
7. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–61.
8. Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, Bakoush O, Contreras G, Genuth S, Klintmalm GB, Poggio E, Rossing P, Rule AD, Weir MR, Kusek J, Greene T, Levey AS: Development and validation of GFRestimating equations using diabetes, transplant and weight. Nephrol Dial Transplant 2009; 25: 449–457.
9. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J: Risk implications of the new CKD Epidemiology Collaboration(CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Diseases 2010; 55: 648–652.
10. Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ: For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009;75: 1071–1078.
11. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT: Performance of the CockcroftGault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size.Clin J Am Soc Nephrol 2010; 5: 1003–1009.
Venugopal B, Sangeeta S. Estimating eGFR using Serum Cystatin C alone and in combination with Serum Creatinine: A Prospective study in individuals with CKD in north Telangana.Perspectives in Medical Research 2018;6(2):12-15.